Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 27;13(8):e0202774.
doi: 10.1371/journal.pone.0202774. eCollection 2018.

Objective assessment of a relative afferent pupillary defect by B-mode ultrasound

Affiliations

Objective assessment of a relative afferent pupillary defect by B-mode ultrasound

Felix A Schmidt et al. PLoS One. .

Abstract

Purpose: To evaluate B-mode ultrasound as a novel method for objective and quantitative assessment of a relative afferent pupillary defect (RAPD) in a prospective case-control study.

Methods: Seventeen patients with unilateral optic neuropathy and a clinically detectable RAPD and 17 age and sex matched healthy controls were examined with B-mode ultrasound using an Esaote-Mylab25 system according to current guidelines for orbital insonation. The swinging flashlight test was performed during ultrasound assessment with a standardized light stimulus using a penlight.

Results: B-mode ultrasound RAPD examination was doable in approximately 5 minutes only and was well tolerated by all participants. Compared to the unaffected contralateral eyes, eyes with RAPD showed lower absolute constriction amplitude of the pupillary diameter (mean [SD] 0.8 [0.4] vs. 2.1 [0.4] mm; p = 0.009) and a longer pupillary constriction time after ipsilateral light stimulus (mean [SD] 1240 [180] vs. 710 [200] ms; p = 0.008). In eyes affected by RAPD, visual acuity correlated with the absolute constriction amplitude (r = 0.75, p = 0.001).

Conclusions: B-mode ultrasound enables fast, easy and objective quantification of a RAPD and can thus be applied in clinical practice to document a RAPD.

PubMed Disclaimer

Conflict of interest statement

F Schmidt has received speaker honoraria from Genzyme, outside the submitted work. K Ruprecht has received research support from Novartis and Bundesministerium für Bildung und Forschung (Competence Network Multiple Sclerosis) as well as speaking fees or travel grants from Guthy Jackson Charitable Foundation and Biogen, outside the submitted work. F Connolly has nothing to disclose. M Maas receives funding from National Institutes of Health grants K23NS092975 and L30NS080176, and has served as a technical consultant for Hyperfine Research, outside the submitted work. F Paul reports grants from BMBF, grants from BMBF, grants from DFG, grants from GJCF, grants from Novartis, personal fees from Bayer, Teva, Genzyme, Merck, MedImmune and Novartis, outside the submitted work. L Harms has received speaker honoraria from Biogen, Teva, Bayer and Novartis. He serves on the advisory board for Roche, Novartis, Genzyme and has received travel support from Biogen, Roche, Bayer and Serono, outside the submitted work. S Schreiber has nothing to disclose. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Comparison of constriction ratio of consensual to direct constriction amplitude between affected and HC eyes.
X-axis: affected eyes and HC eyes. Y-axis: Constriction ratio of consensual to direct constriction amplitudes; the whiskers indicate minimum and maximum values. HC = healthy controls, ON = optic neuritis.
Fig 2
Fig 2. Correlation of visual acuity with absolute constriction amplitude.
X-axis: ACAdir = difference between pupillary diameter at rest and during ipsilateral light stimulus, ON = optic neuritis. Y-axis: VA = visual acuity.

Similar articles

Cited by

References

    1. Bremner FD. Pupil assessment in optic nerve disorders. Eye (Lond) 2004; 18(11):1175–81. - PubMed
    1. Thompson H.S., Corbett J.J., Cox T.A. How to measure the relative afferent pupillary defect. Surv Ophthalmol 1981; 26:39–42. - PubMed
    1. Petzold A, Wattjes MP, Costello F, Flores-Rivera J, Fraser CL, Fujihara K et al. The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 2014; 10(8):447–58. 10.1038/nrneurol.2014.108 - DOI - PubMed
    1. Galetta SL, Villoslada P, Levin N, Shindler K, Ishikawa H, Parr E et al. Acute optic neuritis: Unmet clinical needs and model for new therapies. Neurol Neuroimmunol Neuroinflamm 2015; 2(4):e135 10.1212/NXI.0000000000000135 - DOI - PMC - PubMed
    1. Bennett JL, de Seze J, Lana-Peixoto M, Palace J, Waldman A, Schippling S et al. Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography. Mult Scler 2015; 21(6):678–88 10.1177/1352458514567216 - DOI - PMC - PubMed

LinkOut - more resources